Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

Learn More

VICC toll-free number 1-877-936-8422

Clinical Trial ECOGTHOE1505-M

Title

A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for Patients with Completely Resected Stage IB (> or = 4 cm)- IIIA Non-Small Cell Lung Cancer (NSCLC)

Principal Investigator(s)

John Murray

Details

  • Protocol No. ECOGTHOE1505-M
  • Open Date: 07/27/2007
  • Staging: Phase III
  • Age Group: Adults
  • Scope: National
  • Objective: To evaluate overall survival with chemotherapy with or without Bevacizumab used in the adjuant setting in patients with resected stage IB - IIIA NSCLC.
  • Disease Sites: Non Small Cell
  • Therapies: Chemotherapy - cytotoxic; Molecular Targeted Agents / Immunotherapy / Biologics
  • Drugs: None Specified
  • Participating Institutions: Baptist Hospital; Meharry Medical College
  • Secondary Protocol No: E1505

Description

None Provided.

Eligibility

Not provided. Please call for more information.